咪唑-1-基-(3-硝基苯基)甲酮 | 61652-82-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 咪唑-1-基-(3-硝基苯基)甲酮
• 英文名称: m-nitrobenzoylimidazole
• 英文别名: 1-imidazolyl(3-nitrophenyl)methanone；N-<3-Nitro-benzoyl>-imidazol；1-(3-Nitrobenzoyl)-imidazol；1-(3-nitro-benzoyl)-1H-imidazole；1-(3-Nitro-benzoyl)-1H-imidazol；(1H-Imidazol-1-yl)(3-nitrophenyl)methanone；imidazol-1-yl-(3-nitrophenyl)methanone
• CAS: 61652-82-2
• 化学式: C₁₀H₇N₃O₃
• 分子量: 217.184
• InChiKey: VPQQTPSOQNHFFH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  80.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  咪唑-1-基-(3-硝基苯基)甲酮 在 一水合肼 作用下， 反应 0.02h， 生成 3-硝基苯酰肼
  参考文献：
  名称：

  Khan, Khalid Mohammed; Salar, Uzma; Fakhri, Muhammad Imran, Letters in Organic Chemistry, 2015, vol. 12, # 9, p. 637 - 644

  摘要：

  DOI：
• 作为产物：
  描述：

  咪唑 、 间硝基苯甲酰氯 在 吡啶 、 三乙胺 作用下， 反应 3.17h， 生成 咪唑-1-基-(3-硝基苯基)甲酮
  参考文献：
  名称：

  Imidazole-1-yl pyrimidine derivatives, or pharmacutically acceptable salt thereof, and pharmaceutic composition comprising the same as an active ingredient

  摘要：

  本发明涉及一种新型咪唑-1-基嘧啶衍生物，其药用盐以及包含该衍生物的药物组合物。由于根据本发明，咪唑-1-基嘧啶衍生物显示出对BRAF、BRAF突变体或CRAF的选择性抑制活性，因此可用于预防或治疗癌症的药物组合物。

  公开号：

  US20160200706A1

文献信息

• Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives
  作者：Uzma Salar、Khalid Mohammed Khan、Muhammad Taha、Nor Hadiani Ismail、Basharat Ali、Qurat-ul-Ain、Shahnaz Perveen、Mehreen Ghufran、Abdul Wadood

  DOI：10.1016/j.ejmech.2016.11.031

  日期：2017.1

  Current study is based on the biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives 1–26, by treating metronidazole with different aryl and hetero-aryl carboxylic acids in the presence of 1,1′-carbonyl diimidazole (CDI) as a coupling agent. Structures of all synthetic derivatives were confirmed with the help of various spectroscopic techniques such

  当前的研究基于2-（2-甲基-5-硝基-1 H-咪唑-1-基）乙基芳基羧酸酯衍生物1-26的生物导向药物合成（BIODS），方法是用不同的芳基和甲腈处理甲硝唑。 1,1'-羰基二咪唑（CDI）作为偶联剂存在下的杂芳基羧酸。借助于各种光谱技术，例如EI-MS，1 H - NMR和13 C NMR ，确认了所有合成衍生物的结构。还发现CHN元素分析与计算值一致。评价了合成衍生物以检查其对β-葡萄糖醛酸苷酶的抑制活性，这表明除极少数衍生物外，所有衍生物均在IC范围内表现出良好的抑制作用。50  = 1.20±0.01-60.30±1.40  μ相比于标准的M d -saccharic酸-1,4-内酯（IC 50  = 48.38±1.05  μ M）。化合物1，3，4，6，9 - 19，和21 - 24被发现是有效的类似物和显示出优良的活性比标准。有限的结构-活性关系表明，具有吸电子基团（如NO
• Synthesis of Dithiolethiones and Identification of Potential Neuroprotective Agents via Activation of Nrf2-Driven Antioxidant Enzymes
  作者：Zi-Long Song、Feifei Bai、Baoxin Zhang、Jianguo Fang

  DOI：10.1021/acs.jafc.9b06360

  日期：2020.2.19

  Oxidative stress is implicated in the pathogenesis of a wide variety of neurodegenerative disorders, and accordingly, dietary supplement of exogenous antioxidants or/and upregulation of the endogenous antioxidant defense system are promising for therapeutic intervention or chemoprevention of neurodegenerative diseases. Nrf2, a master regulator of the cellular antioxidant machinery, cardinally participates in the transcription of cytoprotective genes against oxidative/electrophilic stresses. Herein, we report the synthesis of 59 structurally diverse dithiolethiones and evaluation of their neuroprotection against 6-hydroxydopamine- or H2O2 -induced oxidative damages in PC12 cells, a neuron-like rat pheochromocytoma cell line. Initial screening identified compounds 10 and 11 having low cytotoxicity but conferring remarkable protection on PC12 cells from oxidative-mediated damages. Further studies demonstrated that both compounds upregulated a battery of antioxidant genes as well as corresponding genes' products. Significantly, silence of Nrf2 expression abolishes cytoprotection of 10 and 11, indicating targeting Nrf2 activation is pivotal for their cellular functions. Taken together, the two lead compounds discovered here with potent neuroprotective functions against oxidative stress via Nrf2 activation merit further development as therapeutic or chemopreventive candidates for neurodegenerative disorders.
• One-pot synthesis of .beta.-keto sulfones and .beta.-keto sulfoxides from carboxylic acids
  作者：C. Alvarez Ibarra、R. Cuervo Rodriguez、M. C. Fernandez Monreal、F. J. Garcia Navarro、J. Martin Tesorero

  DOI：10.1021/jo00284a043

  日期：1989.11
• <i>C</i>-Acylation of Nitromethane. A Synthetic Route to α-Nitroketones
  作者：David C. BAKER、Sterling R. PUTT

  DOI：10.1055/s-1978-24791

  日期：——
• BAKER D. C.; PUTT S. R., SYNTHESIS, 1978, NO 6, 478-479
  作者：BAKER D. C.、 PUTT S. R.

  DOI：——

  日期：——